“Alternative Therapies: Anti-TNF (Infliximab, And Adalimumab) Agents And Radiological Response For Refractory Sarcoidosis”. The Review of Diabetic Studies (April 18, 2025): 103–119. Accessed October 29, 2025. https://diabeticstudies.org/index.php/RDS/article/view/653.